Author: Ying ZhangPublisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Isolation and Molecular Cloning of a Novel Antimicrobial Peptide with Anti-cancer Activities from the Skin Secretion of Phyllomedusa Hypochondrialis
Author: Ying ZhangA Novel Antimicrobial Peptide with Anticancer Activity from the Skin Secretion of the Frog Phyllomedusa Hypochondrialis
Author: Xiaona XuIsolation and Molecular Cloning of a Novel Antimicrobial Peptide from the Skin Secretion of Fukien Gold-striped Pond Frog, Pelophylaxplancyifukienensis
Author: Xuan LiuIsolation and Molecular Cloning of a Novel Antimicrobial Peptide from the Skin Secretion of Odorrana Schmackeri
Author: Catherine Elizabeth AlexanderPublisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Isolation and Molecular Cloning of Novel Antimicrobial Peptides from the Skin Secretion of Fejervarya Limnocharis
Author: Liling WuIsolation, Characterisation and Molecular Cloning of a Novel Antimicrobial Peptide from the Skin Secretion of Agalychnis Callidryas
Author: Sufang WuIdentification and Molecular Cloning of a Novel Antimicrobial Peptide from the Skin Secretion of Odorrana Livida
Author: Lu XingIsolation and Identification of an Antimicrobial Peptide with High Anticancer Activity and Selectivity, QUB-2584 from the Skin Secretion of Litoria Caerulea
Author: Yifan ZhuIdentification and Molecular Cloning of Novel Antimicrobial Peptides from the Skin Secretion of Lithobates Pipiens
Author: Li LinAntimicrobial and Anticancer Peptides
Author: Neil M. O’Brien-SimpsonPublisher: Frontiers Media SA
ISBN: 2889454703
Category :
Languages : en
Pages : 137
Book Description
In 2014, the World Health Organization (WHO) listed cancer as the second leading cause of death and highlighted antimicrobial resistance as “a key global health challenge” that may, in a worst case scenario, lead to an annual death toll of 10 million by 2050, which would exceed predicted cancer deaths by 20%. Novel promising therapeutic options to reduce morbidity and mortality of both infectious microbial diseases and cancer are being developed based on antimicrobial peptides (AMPs), i.e., evolutionary proven antibiotics that also possess anti-cancer activities. Intriguingly, AMPs and anti-cancer peptides (ACPs) rely typically on novel mechanisms and cellular targets not used by current antibiotics or chemotherapeutics. Initiated by presentations at the International Meeting of Antimicrobial Peptides in 2016 (IMAP 2016), hosted at Leipzig University, Germany, this book compiles the most recent strategies and promising lead compounds for treating multi- and pan-resistant microbes and chemo-resistant cancer cells in fourteen different chapters representing leading research groups from five different continents. In this respect, the book shall stimulate new avenues of thinking and strategies in tackling forthcoming antimicrobial and cancer resistance health threats with the hope that the scenarios recently reported by the WHO will never eventuate.